Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More

Sema4: Andrew Kasarskis

Sema4 has appointed Andrew Kasarskis to the newly created position of chief data officer. Kasarskis will be responsible for establishing additional structures and processes to optimize the company's health intelligence platform and orchestrating data use and data science to support R&D, Sema4 said. He most recently served as executive vice president and chief data officer of the Mount Sinai Health System. Prior to that, he held leadership positions at Pacific Biosciences, Sage Bionetworks, and Merck. He holds a Ph.D. in molecular and cellular biology from the University of California, Berkeley; and a B.S. in biology and B.A. in chemistry from the University of Kentucky.


Strata Oncology: Mark Szewczyk

Strata Oncology has appointed Mark Szewczyk as chief commercial officer. Szewczyk brings more than 25 years of experience in healthcare and commercial leadership in molecular diagnostics, Strata said. He most recently served as vice president of global commercial operations for molecular diagnostics at Abbott. He has also served as general manager in Abbott's molecular diagnostics division; GM of diagnostics imaging systems at Philips Healthcare; and GM of the Cleveland Clinic Home Care. Szewczyk holds an MBA from Drexel University and a B.S. in pharmacy from Ohio State University.


Bionano Genomics: Richard Shippy

Bionano Genomics has added Richard Shippy as chief business officer. Shippy brings over two decades of experience in the life sciences industry. He comes to Bionano from Cradle Genomics, where he was VP of commercial operations and a cofounder. He also was senior director of strategic product marketing in reproductive and genetic health at Illumina and senior director of product marketing at Affymetrix.


For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.